OPK - BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing | Benzinga
ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ -- BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality real world data ("RWD") for the pharmaceutical and life science industries. This collaborative arrangement will offer healthcare providers and researchers unique solutions to inform clinical studies and improve patient outcomes. Combining genetic data and critical biomarkers, means targeted precision therapies based on patients' genetic profiles will be more readily available.
The collaboration combines BioReference Health's expertise in genomic data analysis with Prognos Health's managed RWD marketplace. Prognos is accelerating the development and delivery of innovative therapies and provides an unparalleled collection of health records on more than 325 million de-identified patient health records. Adding genomics will create even more solutions for patients and healthcare ...